These finding are consistent with the results of a previous study where AZD8186 synergized with microtubule inhibitor docetaxel on tumor growth inhibition in xenograft of a PTEN-deficient cell line, HCC-70 breast cancer cells [12]. This evidence concerns the gene PTEN and breast carcinoma.